CAM
REGN icon

Cypress Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Cypress Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,650
Closed -$458K – 138
2019
Q3 		$458K Sell
1,650
-210
-11% -$62.1K 0.16% 107
2019
Q2 		$582K Sell
1,860
-5
-0.3% -$1.67K 0.2% 101
2019
Q1 		$766K Sell
1,865
-108
-5% -$44.5K 0.26% 97
2018
Q4 		$737K Sell
1,973
-575
-23% -$210K 0.28% 91
2018
Q3 		$1.03M Sell
2,548
-357
-12% -$136K 0.3% 89
2018
Q2 		$1M Sell
2,905
-435
-13% -$136K 0.3% 90
2018
Q1 		$1.15M Sell
3,340
-3,791
-53% -$1.32M 0.34% 86
2017
Q4 		$2.68M Sell
7,131
-1,446
-17% -$586K 0.58% 57
2017
Q3 		$3.83M Sell
8,577
-1,343
-14% -$639K 0.83% 41
2017
Q2 		$4.87M Sell
9,920
-2,052
-17% -$898K 1% 34
2017
Q1 		$4.64M Sell
11,972
-722
-6% -$268K 0.89% 36
2016
Q4 		$4.66M Buy
12,694
+89
+0.7% +$33.8K 0.89% 36
2016
Q3 		$5.07M Sell
12,605
-350
-3% -$140K 1.01% 31
2016
Q2 		$4.52M Sell
12,955
-1,125
-8% -$433K 0.9% 32
2016
Q1 		$5.08M Sell
14,080
-65
-0.5% -$26.8K 1.03% 32
2015
Q4 		$7.68M Sell
14,145
-400
-3% -$217K 1.54% 18
2015
Q3 		$6.76M Sell
14,545
-50
-0.3% -$26.9K 1.42% 20
2015
Q2 		$7.45M Hold
14,595
– – 1.4% 22
2015
Q1 		$6.59M Buy
14,595
+2,830
+24% +$1.2M 1.23% 24
2014
Q4 		$4.83M Buy
11,765
+225
+2% +$88.5K 0.89% 36
2014
Q3 		$4.16M Sell
11,540
-1,405
-11% -$471K 0.75% 44
2014
Q2 		$3.66M Sell
12,945
-1,885
-13% -$559K 0.63% 54
2014
Q1 		$4.45M Sell
14,830
-1,655
-10% -$510K 0.81% 41
2013
Q4 		$4.54M Sell
16,485
-400
-2% -$115K 0.79% 41
2013
Q3 		$5.28M Sell
16,885
-35
-0.2% -$9.21K 0.98% 33
2013
Q2 		$3.81M Buy
+16,920
New +$3.94M 0.71% 44

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Cypress Asset Management's REGN Position: Q4 2019 in Review

Cypress Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2019, closing a stake of 1,650 shares — an estimated $458K sold.

Cypress Asset Management first reported a position in REGN in Q2 2013 and held it in 26 quarters. The position peaked at $7.68M in Q4 2015. 703 funds tracked by Wall St. Rank hold REGN as of Q4 2019.

  • Cypress Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Cypress Asset Management sold 1,650 Regeneron Pharmaceuticals shares in Q4 2019, an estimated $458K.
  • Cypress Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 26 quarters.
  • Cypress Asset Management's Regeneron Pharmaceuticals position peaked at $7.68M in Q4 2015.
  • 703 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2019.

Based on Cypress Asset Management's 13F filing for Q4 2019, filed 6 Feb 2020.